FWO - Development of algorithms for datamining in micro array experiments in oncology.
From 01-01-2001 to 31-12-2004
Description
For cancer, the process of diagnosis, staging, prognosis estimation, ... is usually based on empirical criteria. However, the phenotype of the tumor is determined by the collection of disturbed expression levels. By including these expression levels in the clinical decision-making we can take into account the fundamental mechanisms unerlying carcinogenesis. Microarrays allow us to measure these expression levels. However, each microarray experiment produces thousands of values. To gain clinically relevant results we have to use algorithms designed to extract data useful for the medical doctor (data-mining). There are three major tasks to be accomplished by these algo- rithms: 1. Feature selection (detection of relevant genes). 2. Classification of patients. 3. Class discovery (clustering).Team
- Bart De Moor, Promoter
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Research Grant - FWO Research Grant
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.